Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

295.51
+8.603.00%
Post-market: 295.510.00000.00%19:44 EDT
Volume:456.10K
Turnover:134.35M
Market Cap:8.23B
PE:-22.97
High:298.56
Open:290.13
Low:286.00
Close:286.91
52wk High:392.70
52wk Low:50.31
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.97
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:6.14
PE(LYR):-21.93

Loading ...

Praxis Precision price target raised to $166 from $130 at Wedbush

TIPRANKS
·
May 08

Wedbush Remains a Sell on Praxis Precision Medicines (PRAX)

TIPRANKS
·
May 08

Deutsche Bank Adjusts Praxis Precision Medicines Price Target to $420 From $444, Maintains Buy Rating

MT Newswires Live
·
May 08

Praxis Precision Medicines Inc : Wedbush Raises Target Price to $166 From $130

THOMSON REUTERS
·
May 08

Praxis Precision Medicines, Inc. : Deutsche Bank Cuts Target Price to $420 From $444

THOMSON REUTERS
·
May 08

H.C. Wainwright Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)

TIPRANKS
·
May 08

Praxis Precision Med Price Target Maintained With a $843.00/Share by BTIG

Dow Jones
·
May 08

Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target

TIPRANKS
·
May 08

Praxis Precision Medicines publishes corporate presentation on CNS pipeline, near-term regulatory catalysts

Reuters
·
May 07

Praxis Precision's Q1 net loss widens on higher expenses

Reuters
·
May 07

Praxis Precision Medicine Q1 EPS $(3.20) Beats $(3.50) Estimate

Benzinga Earnings
·
May 07

BRIEF-Praxis Precision Q1 EPS USD -3.2

Reuters
·
May 07

Praxis Precision Q1 Operating Income USD -105.86 Million

THOMSON REUTERS
·
May 07

Praxis Precision Q1 Net Income USD -92.561 Million

THOMSON REUTERS
·
May 07

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Praxis Precision Medicines grants 5,420 RSUs to 21 new employees under inducement plan

Reuters
·
May 06

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06

Praxis Precision Medicines Inc expected to post a loss of $3.57 a share - Earnings Preview

Reuters
·
May 05

Praxis Precision Medicines updates financial calendar for first-quarter results and investor conference

Reuters
·
May 05

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

GlobeNewswire
·
May 05